A Comparison Study of the Maxi Move 5 (MM5) Device

August 13, 2024 updated by: Arjo AB

A Laboratory Trial to Explore the Benefits of the New Maxi Move 5 (MM5) Technology

This trial aims to evaluate the added improvements from a caregiver and patient benefit perspective.

The trial should identify the forces involved for the caregiver when manoeuvring the lift.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Loughborough, United Kingdom
        • School of Design and Creative Art at Loughborough University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

For expert patient:

  • ≥18 years
  • Healthy male or female
  • 80-100 kg

    24 healthy volunteers (caregivers) will be recruited. They will require a strong working knowledge of passive floor lifts and patient positioning with the use of loop and clip slings.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Maxi Move 5
24 healthy volunteers will evaluate all 5 devices
4 comparative devices will be used to evaluate the MM5 device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
1. Time to complete each transfer will be recorded
Time Frame: up to 24 months
Time to complete each activity and each task within the activity will be measured in seconds.
up to 24 months
2. A detailed hierarchical task analysis (HTA) of each activity will be completed using the video recordings and experimenter field notes for each transfer to asses the number of correct placements for each device.
Time Frame: up to 24 months
Correct placement will be visually controlled with the use of markers on the subject and the final positioning device (e.g chair, toilet or bed) for each transfer. This will be reported as distance from the ideal position.
up to 24 months
3. Physical load for movement of the hoist throughout the activities for each device will be measured.
Time Frame: up to 24 months
Force required to complete the range of patient and hoist positioning tasks, forward, backwards, rotation movement, patient positioning etc. These forces will be used with the HTA data to calculate the amount of physical force delivered by the participants with each device and each transfer. The forces used will be presented in newton.
up to 24 months
4 Collect subjective data from the caregivers that describe, comfort, ease of use, effort and willingness to adopt in practice, etc
Time Frame: up to 24 months
This will be collected by the use of questionnaires
up to 24 months
5 Subjective responses from the expert patient being transferred will be recorded
Time Frame: up to 24 months
This will be collected by the use of questionnaires
up to 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Study Director: Karin Hannander, Arjo AB

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 20, 2023

Primary Completion (Actual)

February 28, 2024

Study Completion (Actual)

May 31, 2024

Study Registration Dates

First Submitted

October 23, 2023

First Submitted That Met QC Criteria

December 7, 2023

First Posted (Actual)

December 18, 2023

Study Record Updates

Last Update Posted (Actual)

August 14, 2024

Last Update Submitted That Met QC Criteria

August 13, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • MaxiMove5-MACC-001-2023

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

Clinical Trials on Maxi Move 5

Subscribe